Homocysteine: A Risk Factor in Patietns with Cardiovascular Disorders in Pakistan

E-ISSN： 1875-6646|11|4|210-214

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.11, Iss.4, 2015-12, pp. : 210-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs Affecting Homocysteine Metabolism: Impact on Cardiovascular Risk

By Desouza C. Keebler M. McNamara D.B. Fonseca V.

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 605-616

Adis International

Access to resources Recommend Favorite

Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1923-1929

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue factor pathway inhibitor for cardiovascular disorders

By Kaiser B. Hoppensteadt D.A. Fareed J.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 1, 2000-02 ,pp. : 73-87

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonates: dental disorders a risk factor for jaw osteonecrosis

Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

By Hoppensteadt Debra A Kaiser Brigitte Fareed Jawed

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1925-1935

Informa Healthcare

Access to resources Recommend Favorite